Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsMR Image Analysis Software - MRI Brain Parcellation

Vendor source

Reviewed 11 May 2026

Completeness Strong (64%)

MR Image Analysis Software - MRI Brain Parcellation

United Imaging Intelligence

The MRI Brain Parcellation application is intended to provide a automatic tool for segmenting, quantifying and visualizing of brain regions from a set of brain MR images，and indicates abnormal regions based on normative reference database to assess the brain condition.

Supported by 1 paper

Key features

Quantative comparison results of each brain regions with normative database

Quantification of brain regions

Segmentation of brain regions

General Information

Product name

MR Image Analysis Software - MRI Brain Parcellation

Modality

MR

Main task

Quantification, Segmentation

Subspeciality

Neuro

Disease targeted

Brain disorders (e.g. Alzheimer's disease (AD), Parkinson's disease), normal brain structure research on healthy individuals

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Adult, Elderly, Pediatric

Input

MRI brain images

Input format

DICOM

Output

Segmentation of brain regions, Quantification of brain regions, Quantitative comparison results of each brain regions with normative database, Follow-up chart, Overall map, Atrophy pattern map, Report

Output format

Not specified

Integration

Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition

Processing time

Not specified

Population

Use in patients aged 0–90 on brain MRI scans; standalone use. Caution: not clinically validated for 1) prior intracranial surgery; 2) intracranial mass, hemorrhage, or trauma; 3) encephalomalacia or intracranial calcification; 4) poor image quality or incomplete scan coverage.

Market Presence

On market since

08-2025

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

One-time license fee, Pay-per-use, Subscription

Based on

Number of analyses, Number of installations, Number of users

Source: Vendor | First published: Oct 22, 2025 | Last updated: May 11, 2026